Endothelin-1, superoxide and adeninediphosphate ribose cyclase in shark vascular smooth muscle by Fellner, Susan K. & Parker, Laurel
1045
It is becoming well accepted that peptide agonist
stimulation of G protein-coupled receptors, generation of
inositol trisphosphate (IP3) and activation of the IP3 receptor
(IP3R) causes a release of Ca2+ of short duration from the
endoplasmic/sarcoplasmic reticulum (ER/SR; Berridge,
1993; Galione and Churchill, 2002; Guse et al., 1999). This
Ca2+ signal is augmented by activation of the ryanodine
receptor (RyR) by the increase in cytosolic Ca2+
concentration ([Ca2+]i; a process known as calcium-induced
calcium release, CICIR), by cyclic adenine-diphosphoribose
(cADPR) and possibly by IP3 as well (Galione and Churchill,
2002; Yusufi et al., 2002; Guse et al., 1999). cADPR, first
discovered in sea urchin eggs (Lee et al., 1989), is
synthesized from β-nicotinamide adenine dinucleotide
(NAD+) by a bifunctional membrane bound enzyme, CD38,
in a wide variety of eukaryotic cells (Guse, 1999; Lee, 2001).
cADPR, in concert with calmodulin, sensitizes the ryanodine
receptor (RyR) to Ca2+, thereby amplifying the process of
CICR (Galione et al., 1991; Lee, 1993; Dousa et al., 1996)
and can directly stimulate the RyR (Yusufi et al., 2001; Li et
al., 2001).
Evidence for the presence of an ADPR cyclase and for a
role of cADPR in Ca2+ signaling has been established in a
large number of mammalian cell types (Guse, 1999; Lee,
2001). There are only two reports of cADPR activity in fish,
both in oocytes (Polzonetti et al., 2002; Fluck et al., 1999).
Recently we demonstrated a role for cADPR in endothelin B
receptor (ETBR)-mediated Ca2+ signaling in the anterior
mesenteric artery of Squalus acanthias (Fellner and Parker,
2004). Participation of cADPR in Ca2+ signaling has been
demonstrated from a variety of mammalian vascular smooth
muscle (VSM) sources: membrane preparations of rat aorta
(Yusufi et al., 2002; de Toledo et al., 2000), renal microvessels
(Li et al., 2000), bovine and porcine coronary arteries (Zhang
et al., 2004; Yu et al., 2000; Kannan et al., 1996), and
pulmonary artery (Wilson et al., 2001). The VSM ADPR
cyclase has several unique properties that distinguish it from
CD38. In contrast to the ADPR cyclase of sea urchin eggs,
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In vascular smooth muscle (VSM) of Squalus acanthias,
endothelin-1 (ET-1) signals via the ETB receptor. In both
shark and mammalian VSM, ET-1 induces a rise in
cytosolic Ca2+ concentration ([Ca2+]i) via activation of
the inositol trisphosphate (IP3) receptor (IP3R) and
subsequent release of Ca2+ from the sarcoplasmic
reticulum (SR). IP3R-mediated release of SR Ca2+ causes
calcium-induced calcium release (CICR) via the ryanodine
receptor (RyR), which can be sensitized by cyclic
adeninediphosphate ribose (cADPR). cADPR is
synthesized from NAD+ by a membrane-bound
bifunctional enzyme, ADPR cyclase. We have previously
shown that the antagonists of the RyR, Ruthenium Red,
high concentrations of ryanodine and 8-Br cADPR,
diminish the [Ca2+]i response to ET-1 in shark VSM. To
investigate how ET-1 might influence the activity of the
ADPR cyclase, we employed inhibitors of the cyclase. To
explore the possibility that ET-1-induced production of
superoxide (O2.–) might activate the cyclase, we used an
inhibitor of NAD(P)H oxidase (NOX), DPI and a
scavenger of O2.–, TEMPOL. Anterior mesenteric artery
VSM was loaded with fura-2AM to measure [Ca2+]i. In
Ca2+-free shark Ringers, ET-1 increased [Ca2+]i by
104±8·nmol·l–1. The VSM ADPR cyclase inhibitors,
nicotinamide and Zn2+, diminished the response by 62%
and 72%, respectively. Both DPI and TEMPOL reduced
the response by 63%. The combination of the IP3R
antagonists, 2-APB or TMB-8, with DPI or TEMPOL
further reduced the response by 83%. We show for the
first time that in shark VSM, inhibition of the ADPR
cyclase reduces the [Ca2+]i response to ET-1 and that
superoxide may be involved in the activation of the
cyclase.
Key words: NAD(P)H oxidase, nicotinamide, CICR, ryanodine,
calcium, shark, Squalus acanthias.
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Aplysia and HL-60 cells, in which Zn2+ enhances the activity
of the enzyme, Zn2+ inhibits the cyclase of rat aortic VSM
cells (de Toledo et al., 2000). Furthermore, the VSM cyclase
has a specific activity 20-fold greater than the CD38 of HL 60
cells (de Toledo et al., 2000), suggesting that the enzyme may
play an important role in normal vascular physiology.
Recently, it has been shown that oxidative stress increases
[Ca2+]i in fresh bovine coronary VSM cells (Zhang et al.,
2004) and that nitric oxide (NO) inhibits ADPR cyclase in
bovine coronary artery. These findings contrast with the
stimulatory effect of NO in non-vascular cells such as
macrophages, pancreatic cells, neurons and sea urchin eggs
(Yu et al., 2000).
Evidence for participation of cADPR in endothelin-1 (ET-
1) Ca2+ signaling has been demonstrated in porcine airway
smooth muscle (White et al., 2003), rat seminiferous
peritubular smooth muscle (Barone et al., 2002), rat mesenteric
artery (Giulumian et al., 2000) and shark mesenteric artery
VSM (Fellner and Parker, 2004). None of these studies has
explored the mechanism(s) by which ET-1 might activate the
ADPR cyclase. A link between ET-1 and the generation of
superoxide (O2.–) has been demonstrated in cultured A-10 cells
(Sedeek et al., 2003) and human gluteal arterial VSM cells
(Touyz et al., 2004). We hypothesized that ET-1 might activate
VSM NAD(P)H oxidases (NOX) causing the generation of
O2.– leading to the activation of the VSM ADPR cyclase.
Therefore, in the current study we utilized inhibitors of the
ADPR cyclase, an inhibitor of NOX and a superoxide
dismutase mimetic to investigate how ET-1 might activate the
cyclase to generate cADPR. Because our previous
investigations of Ca2+ signaling pathways in shark VSM have
demonstrated remarkable concordance with those of
mammalian VSM (Fellner and Parker, 2004), we believe that
the current study can give insight into the role of superoxide,
preserved during evolution, in the responses of VSM to peptide
agonists.
Materials and methods
Sharks Squalus acanthias L. (2–3·kg) of both sexes were
caught in the coastal waters of Maine, USA and kept in running
seawater tanks (11–15°C, early to late summer) until the
animals were pithed through the snout and sacrificed. This
protocol was approved by the Institutional Animal Care
Committee at Mount Desert Island Biological Laboratory,
Salisbury Cove, ME, USA.
The anterior mesenteric artery was dissected and placed in
ice-cold Ca2+-free shark Ringers, pH 7.7, containing, in
mmol·l–1, NaCl, 275; KCl, 4; MgCl2, 3; Na2SO4, 0.5;
KH2PO4, 1.0; NaHCO3, 8; urea, 350; D-glucose, 5; Hepes, ~5,
and trimethylamine oxide (TMAO), 72 (Fellner and Parker,
2002). Calcium buffer contained 2.5·mmol·l–1 calcium
(normal concentration in the shark; Prosser and Kirschner,
1973), whereas no CaCl2 was added to the calcium-free
buffer. The anterior mesenteric artery was minced into pieces
<0.5·mm in size and then loaded with the Ca2+-sensitive
fluorescent dye, fura-2AM at 13°C for 30·min in the dark in
Ca2+-Ringers containing 0.5% bovine serum albumin (BSA);
the sample was washes three times with Ca2+-free buffer
and incubated for another 30·min at 18°C. Subsequent
experiments were conducted in a temperature-controlled
room kept at 18°C.
Measurement of cytosolic free calcium concentration
[Ca2+]i was measured as previously described (Fellner and
Parker, 2004; Fellner and Parker, 2002). Arterial tissue was
placed in an open static chamber and examined in a small
window of the optical field of a ×40 oil-immersion
fluorescence objective of an inverted microscope (Olympus
IX70). All experiments were conducted in a room maintained
at 18°C. Approximately 5–6 typical elongated vascular smooth
muscle cells were selected for analysis. There were no visible
endothelial cells in the study sample. The tissue was excited
alternately with light of 340 and 380·nm wavelengths from a
dual-excitation wavelength Delta-Scan equipped with dual
monochronometers and a chopper (Photon Technology
International (PTI), New Jersey, USA). After passing signals
through a barrier filter (510·nm), fluorescence was detected by
a photomultiplier tube. The calibration of [Ca2+]i was based on
the signal ratio at 340/380·nm and known concentrations of
Ca2+ (Grynkiewicz et al., 1985) and was performed with a
calibration kit purchased from Molecular Probes (Eugene, OR,
USA).
Experimental protocol
The concentrations of ET-1 that we employed in each
experiment was 2×10–7·mol·l–1, a concentration at least twice
the maximal stimulatory concentrations reported in the
literature (Just et al., 2004; Touyz et al., 1995; Shimoda et al.,
2000; Yanagisawa et al., 1988; Cavarape et al., 2003; Batra et
al., 1993). The concentrations of antagonists were also chosen
on the basis of values reported in the literature: Zn2+
(3·mmol·l–1) (de Toledo et al., 2000), nicotinamide
(3·mmol·l–1) (Sethi et al., 1996), 4-hydroxy-2,2,6,6-tetramethyl
piperidinoxyl (TEMPOL; 1·mmol·l–1) (Zhang et al., 2004;
Touyz et al., 2004) and diphenyl iodonium (DPI; 1·µmol·l–1)
(Touyz et al., 2004; Rodriguez-Puyol et al., 2002). Tissue was
preincubated with antagonists for at least 2·min before adding
ET-1.
Mesenteric VSM cells were analyzed only once and then
discarded. All experiments were conducted initially in Ca2+-
free Ringers. After responses to ET-1 in the presence or
absence of inhibitors had concluded, we added Ca2+ (final
concentration, 2.5·mmol·l–1), to confirm tissue viability.
Calcium entry via store-operated channels or voltage-gated
channels as well as operation of the calcium sensing receptor
(Fellner and Parker, 2002) should increase [Ca2+] i. In the case
of the Zn2+ experiments however, because Zn2+ inhibits
voltage-gated Ca2+ entry (Kerchner et al., 2000) and possibly
store-operated Ca2+ entry (Uehara et al., 2002), the effect of
adding Ca2+ was markedly diminished. If there was no Ca2+
response, that sample was discarded.
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Reagents
Trimethylamine oxide (TMAO), nicotinamide, DPI, 2-
aminoethoxy diphenyl borate (2-APB) and TEMPOL were
purchased from Sigma (St Louis, MO, USA), endothelin-1 from
California Peptide Research, Inc (Napa, CA, USA), fura-2-AM
from Teflab (Austin, TX, USA) and 3,4,5-trimethoxybenzoic
acid-8-(diethylamino) octyl ester (TMB-8; CalBiochem, La
Jolla, CA, USA).
Statistics and graphics
The data are presented as means ± S.E.M. Each data set is
derived from tissue originating from at least three different
sharks. For representative tracings of original data with ET-1
and antagonists, we selected data pairs from the same
experimental day. Paired data sets were tested with Student’s
paired t-test. Multiple comparisons were analyzed using one-
way analysis of variance for repeated measures followed by
Student–Neuman–Kuels post hoc test. P<0.05 was considered
statistically significant.
Results
[Ca2+]i response to ET-1
Mesenteric artery VSM cells in Ca2+-free Ringers responded
to ET-1 with a peak response in 5–25·s. As we reported
previously, the response of shark VSM cells to ET-1 at cool
temperatures is characterized by a broad peak, which falls back
to baseline values in approximately 100·s (Fellner and Parker,
2004). Based on the techniques employed in the present study,
we found that the mean baseline [Ca2+]i was 116±6 and the peak
response to ET-1 was 220±9·nmol·l–1 (N=53, P<0.01; Fig.·1).
(The apparent [Ca2+]i is denoted simply as [Ca2+]i.) Thus the
net increase in [Ca2+]i after ET-1 stimulation for all experiments
was 104±8·nmol·l–1. Addition of Ca2+ at the nadir of the ET-1
response caused a further increase in [Ca2+]i of 115±9·nmol·l–1.
Inhibitors of the ADPR cyclase
A major question is what is the relationship between agonist
stimulation of a G-protein-coupled receptor to initiate the
sequence of IP3 generation, activation of the IP3R, release of
Ca2+ from the SR and participation of the RyR to augment the
Ca2+ signal? And further, what is the communication between
ET-1 and the membrane ADPR cyclase to direct formation of
cADPR? If inhibitors of the ADPR cyclase diminish the
response of VSM cells to ET-1, one might infer that ET-1 is
somehow sending a message to the cyclase to increase the
formation of cADPR. Both nicotinamide and Zn2+ are well-
studied inhibitors of the ADPR cyclase in vascular smooth
muscle (de Toledo et al., 2000; Sethi et al., 1996). Neither of
these antagonists is known to have an effect on the IP3 receptor
(IP3R). Nicotinamide (3·mmol·l–1) pretreatment of arterioles
reduced the [Ca2+]i response to ET-1 by 62% (40±6·nmol·l–1;
N=15, P<0.01 for ET-1 alone vs ET-1 + nicotinamide;
Fig.·2A,C). In the presence of Zn2+ (3·mmol·l–1), the net
response to ET-1 was decreased to 30±3 nmol·l–1 (72%
inhibition; N=11, P<0.01; Fig.·2B,C). Together, the
nicotinamide and Zn2+ experimental data suggest that there is a
pathway utilized by ET-1 that increases the activity of the
ADPR cyclase and that is independent of the IP3 pathway.
Blockade of superoxide generation or effect
To address the question of whether there is a connection
between ET-1, O2.– generation and ET-1-induced elevation of
[Ca2+]i, we employed the NOX inhibitor DPI (Babior, 1999;
Touyz et al., 2004). In the presence of DPI (1·µmol·l–1), the
increase in [Ca2+]i following addition of ET-1 was 39±7 (N=19,
P<0.01 for ET-1 + DPI vs baseline, and 0.05 for ET alone vs
ET + DPI; Fig.·3A,C). To further examine the role of O2.– in
ET-1-mediated Ca2+ signaling in shark VSM, we utilized
TEMPOL, a superoxide dismutase mimetic (Evans et al., 2004;
Sedeek et al., 2003). When the VSM was preincubated with
TEMPOL (1·mmol·l–1), the increase in [Ca2+]i was 38±3 (N=19,
P<0.05 for ET-1 + TEMPOL vs baseline, and <0.01 for ET-1
vs ET-1 + TEMPOL; Fig.·3B,C). These data, showing 63%
inhibition of the ET-1-induced [Ca2+]i response by DPI and
TEMPOL, suggest that when the production or duration of
elevated O2.– is diminished, the ability of ET-1 to mobilize Ca2+
from the SR and increase [Ca2+]i is markedly reduced.
Simultaneous blockade of the IP3R and O2.– generation or
effect
To substantiate the premise that ET-1 signals via two
independent pathways, namely the classic IP3 pathway and
perhaps a NOX, O2.–, ADPR cyclase pathway, we measured
the [Ca2+]i response to ET-1 in the presence of added TEMPOL
or of DPI plus 2-APB (33·µmol·l–1) or DPI plus TMB-8
(1·µmol·l–1). We were unable to test TEMPOL plus TMB-8
because of precipitation when the two reagents were combined.
The [Ca2+]i response to ET-1 in the presence of TEMPOL plus
2-APB was 19±6·nmol·l–1 (82% inhibition, N=6, P<0.01 vs
TEMPOL alone). For DPI plus 2-APB, the [Ca2+]i response
was 17±6·nmol·l–1 (84% inhibition, N=8, P=0.02 vs DPI
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Fig.·1. Representative tracing of cytosolic Ca2+ ([Ca2+]i) response of
shark anterior mesenteric artery vascular smooth muscle (VSM) to
endothelin-1 (ET-1) in Ca2+-free shark Ringers followed by the
addition of Ca2+ (2.5·mmol·l–1).
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alone). For DPI plus TMB-8, the response was 18±4·nmol·l–1
(83% inhibition, N=9, P=0.01 vs DPI alone; Fig.·4).
Discussion
We have previously shown that G-protein-coupled
activation of the ETBR, leading to IP3 formation and
stimulation of the IP3R, is a major signaling pathway for
increasing [Ca2+]i in VSM cells of the anterior mesenteric
artery of Squalus acanthias (Fellner and Parker, 2004).
Furthermore, we demonstrated that three antagonists of the
RyR, Ruthenium Red, high concentrations of ryanodine and 8-
Br cADPR inhibited the response by a mean 39% (Fellner and
Parker, 2004). In the present study, we have investigated ET-
1-stimulated participation in the activation of the ADPR
cyclase and show that ET-1 somehow has an effect on the
formation of cADPR. To investigate the possibility that ET-1
influences the activity of the ADPR cyclase, we utilized two
inhibitors of this plasmalemmal membrane enzyme,
nicotinamide (Sethi et al., 1996) and Zn2+ (de Toledo et al.,
2000). Both nicotinamide and Zn2+ inhibited the [Ca2+]i
response to ET by about 60%. Nicotinamide does not actually
inhibit the cyclase, but rather forces the reaction in the
direction of forming NAD+ rather than cADPR (Kim et al.,
1993). Nicotinamide is not known to influence any other
components of ET-1 signaling pathways (Geiger et al., 2000).
Although Zn2+ can block voltage-gated Ca2+ entry (Kerchner
et al., 2000) and possibly store-operated Ca2+ entry (Uehara et
al., 2002), these pathways are not operative in Ca2+-free buffer.
Zn2+ can also inhibit the plasma membrane Ca2+ ATPases of
fish gill (Hogstrand et al., 1996), and in so doing, reduces Ca2+
efflux from the cell. If this were a significant effect in VSM
cells, one would expect an enhancement of the [Ca2+]i response
to ET-1, rather than inhibition. Zn2+ may inhibit proton
currents associated with NOX in phagocytic cells (DeCoursey
et al., 2003). Whether or not Zn2+ interacts with the novel
isoforms of VSM NOX (Bengtsson et al., 2003) has not been
studied. The strong inhibitory effects of both nicotinamide and
Zn2+ provide firm evidence that ET-1 is involved in the
activation of the ADPR cyclase to form cADPR in VSM of S.
acanthias.
An enzyme capable of forming cADPR was first described
in homogenates of sea urchin eggs (Lee et al., 1989) and
subsequently has been shown to be present in a wide variety
of cell types (Lee, 1997; Guse, 1999, 2004). In mammals, a
single bifunctional protein, CD38, can act as a cyclase or
hydrolase for cADPR (Lee et al., 1997; reviewed by Schuber
and Lund, 2004). This unusual membrane-bound enzyme is
stimulated by a number of different agonists in specific
mammalian cell types: for example, estrogen in myometrium
(Barata et al., 2004); glucose in pancreatic beta cells
(Takasawa et al., 1993); retinoic acid and triiodothyronine (T3)
in aortic VSM cells (de Toledo et al., 1997); reactive oxygen
species (ROS) in bovine coronary VSM (Zhang et al., 2004);
angiotensin II in neonatal cardiac myocytes (Higashida et
al., 2000), tumor necrosis factor-α and interleukin 1-β in
glomerular mesangial cell (Yusufi et al., 2001), and
acetylcholine and ET-1 in airway smooth muscle (White et al.,
2003). How this structurally diverse group of molecules
mediates the same process, namely activation of the ADPR
cyclase, has not yet been elucidated with certainty.
NAD(P)H oxidases are plasmalemmal enzymes that
catalyze the production of (O2.–) from two molecules of O2
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Fig.·2. Effect of inhibitors of ADPR cyclase on endothelin-1 (ET-1)-
stimulated increases in [Ca2+]i in vascular smooth muscle (VSM). (A)
Representative tracing of the [Ca2+]i response to ET-1 in the presence
and absence of nicotinamide. (B) Representative tracing of the
response to ET-1 in the presence and absence of Zn2+. (C) Summary
data of the effects of nicotinamide (N=15) and Zn2+ (N=11) on the
ET-1-induced peak elevation of [Ca2+]i. *P<0.01 for both inhibitors
vs ET-1 alone.
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(reviewed by Babior, 1999). Although widely studied in
phagocytic cells, NOX has been more recently found to be
present in VSM and to be activated by peptide agonists such
as angiotensin II (Rajagopalan et al., 1996). There is now
evidence for ET-1-induced activation of NOX and formation
of superoxide (O2.–) and reactive oxygen species (ROS) in
VSM (Sedeek et al., 2003; Touyz et al., 2004; Li et al., 2003;
Galle et al., 2000; Wedgwood et al., 2001). In cultured rat
aortic VSM cells, ET-1 dose dependently (10–8 to 10–6 mol·l–1)
increased the formation of O2.– (Sedeek et al., 2003) and, in
human gluteal VSM cells, similar results were noted (Touyz et
al., 2004). DPI, an inhibitor of NOX, diminished the ET-1-
induced production of O2.– only at high concentrations of
ET (10–6·mol·l–1) whereas thenotrifluoroacetone (TIFT), a
mitochondrial electron chain inhibitor, reduced the production
of O2.– at concentrations of ET-1 between 10–9 and 10–6·mol·l–1
(Touyz et al., 2004). To our knowledge, there have been no
reports of a vascular smooth muscle NOX, or NOX of any non-
phagocytic cell origin, in fish. Our finding of inhibition of the
[Ca2+]i response to ET-1 by the NOX inhibitor DPI and by the
superoxide dismutase mimetic, TEMPOL, lends support to
the presence of generation of O2.– by NOX on VSM of S.
acanthias.
Recent studies have investigated a possible linkage between
O2.– generation, cADPR and changes in [Ca2+]i, and vascular
contraction in small bovine coronary arteries (Zhang et al.,
2004). Xanthine/xanthine oxidase (X/XO), a O2.– generating
system, increased the activity of ADPR cyclase and increased
[Ca2+]i in fresh coronary artery VSM cells. The elevation in
[Ca2+]i was partially blocked by 8-Br cADPR, nicotinamide,
high concentrations of ryanodine and tetracaine (Zhang et
al., 2004). Other studies have likewise suggested that O2.–
increases that activity of ADPR cyclases (Xie et al., 2003;
Okabe et al., 2000). In cardiac myocytes, nearly nanomolar
concentrations of O2.– stimulated the synthesis of cADPR and
Ca2+ release (Okabe et al., 2000). Oxidation of cysteine
residues of the cyclase results in the formation of disulfide
bond and dimers of the enzyme, which have much greater
activity than the monomer (Tohgo et al., 1994; Chidambaram
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Fig.·3. Effect of NAD(P)H oxidase inhibitor (DPI) and superoxide
dismutase mimetic (TEMPOL) on endothelin-1 (ET-1) stimulation of
[Ca2+]i in shark vascular smooth muscle (VSM). (A) Typical tracing
of the [Ca2+]i response to ET-1 in the presence and absence of DPI.
(B) Typical tracing of the ET-1 in the presence and absence of
TEMPOL. (C) Summary data showing the inhibitory effects of DPI
(N=19) and TEMPOL (N=19) on the ET-1 induced elevation of










































Fig.·4. Effects of combining inhibitors of the IP3 receptor with an
inhibitor of NAD(P)H oxidase (DPI) or a superoxide scavenger
(TEMPOL) in Ca2+-free shark Ringers. In each case, the combination
of antagonists blocked the [Ca2+]i response to endothelin-1 (ET-1) by
83±1%. *P<0.01.
THE JOURNAL OF EXPERIMENTAL BIOLOGY
1050
induced formation of O2.– may acutely increase the activity of
ADPR cyclase, possibly via dimerization of the enzyme.
Superoxide generation may have other effects on [Ca2+]i and
the activity of ADPR cyclase. Superoxide rapidly combines
with nitric oxide (NO) to form peroxynitrate (Gryglewski et
al., 1986). Nitric oxide has been shown to inhibit the ADPR
cyclase of bovine coronary arterial VSM cells (Yu et al., 2000).
Thus, ET-1-stimulated O2.– production may diminish available
NO, thereby abolishing the usual inhibitory effect of NO on
the cyclase, and increasing both the ability of the cyclase to
form cADPR and its participation in CICR. There are vascular
effects of O2.– that are independent of cADPR. Nitrosylation
of tyrosine residues may impair the synthesis of prostacyclin,
which is vasodilatory (Zou et al., 1997). Superoxide may
combine non-enzymatically with arachidonate, generating
isoprostanes, which can then activate thromboxane receptors
(Seshiah et al., 2002). Thus there are several possible
mechanisms by which ET-1 stimulated O2.– formation could
have an effect on Ca2+ in VSM.
Our finding that DPI or TEMPOL plus 2-APB or TMB-8
inhibited the [Ca2+]i response to ET-1 in afferent arterioles by
83% raises the question of why there was not 100% inhibition.
It is possible that neither the IP3R nor O2.– blockers were given
at maximal inhibitory concentrations. There may be other
pathways of ET-1-induced calcium signaling such as receptor-
operated mechanisms, working through diacyl glycerol rather
than IP3. Our data suggest that blockade of the IP3R represents
the sum of IP3R-mediated release of Ca2+ from the SR and that
obtained from CICR. Anything that interferes with generation
or disposition of O2.–, will reduce activation of the ADPR
cyclase, production of cADPR and sensitization of the RyR to
Ca2+. The inhibitors of the ADPR cyclase, nicotinamide and
Zn2+, diminished the [Ca2+]i response to ET-1 by two thirds.
Similarly, both DPI and TEMPOL reduced the response by
about two thirds, suggesting that the effect of cADPR on the
RyR is a major component of the global response of afferent
arteriolar VSM to ET-1.
Complex control systems have developed in animals to
ensure homeostasis in response to intermittent feeding
conditions and to environmental changes. The well-known
initiating event in contraction of vascular smooth muscle is a
change in [Ca2+]i caused by hormones, autocrine or paracrine
substances or stretch of the vascular wall. Endothelin-1, which
is produced by the vascular endothelium, acts locally to cause
vasoconstriction. In all animals, the ability to regulate systemic
blood flow in the face of environmental stresses has great
survival benefit. The elasmobranch, Squalus acanthias,
controls plasma osmolality and blood volume by secreting
hypertonic fluid from its rectal gland. We have previously
proposed that changes in blood flow to the rectal gland are
important modulators of salt excretion from the rectal gland
(Fellner and Parker, 2002). As well, ET-1 is thought to have
an important role in influencing gill function in the shark
(Evans and Gunderson, 1999).
In summary, we have shown that ET-1 stimulation of the
anterior mesenteric artery VSM of the shark increases [Ca2+]i
via several distinct pathways. The classic G-protein-coupled
receptor activation that results in IP3 generation and release of
[Ca2+]i from the SR probably provides an initial increase of
[Ca2+]i. The IP3R-stimulated increase in [Ca2+]i can initiate
CICR. Our data suggest that in S. acanthias, ET-1 activates
NOX to produce O2.– which, in turn, activates VSM ADPR
cyclase to increase the formation of cADPR. cADPR, with its
interaction with the RyRs, further amplifies the Ca2+ signal.
These findings demonstrate that vascular NOX and ADPR
cyclase are enzymes that have been preserved for millions of
years during evolution.
This work was supported in part by a grant from the
Thomas H. Maren Foundation.
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